CYP2C19 Status and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: Insights From the EUCLID Trial

2020 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    5
    References
    0
    Citations
    NaN
    KQI
    []